MISTY SMITH

Research Associate Professor

School of Dentistry

RESEARCH INTERESTS

Dr. Smith is a behavioral pharmacologist whom serves as a Co-Investigator in the NIH-sponsored Anticonvulsant Drug Development (ADD) Program in the Department of Pharmacology and Toxicology in the College of Pharmacy. Dr. Smith's current research is investigating the therapeutic potential of novel compounds, such as cannabidiol and other minor cannabinoids, for the treatment of epilepsy and its comorbidities.   Current projects  are focused on pharmacologically characterizing the drug interactions, safety and efficacy of combinations of antiseizure medications with cannabidiol or cannabidiol with other minor cannabinoids. Other research interests include developing the pharmacotherapeutic potential of neuropeptides, endocannabinoids and other novel therapeutics in the treatment of chronic pain, substance abuse and other neuropsychiatric conditions. 

GRANTS

  • EXTERNAL GRANT OR CONTRACT
    Isobolographic Analyses of Cannabidiol Interactions with Antiseizure Drugs
    Epilepsy Foundation of America11 Jan 2014 - 31 Dec 2016
    Epilepsy Foundation of America
  • EXTERNAL GRANT OR CONTRACT
    CANNABIDIOL ISOBOLOGRAMS
    EPILEPSY FOUNDATION1 Jan 2014 - 31 Dec 2016
    EPILEPSY FOUNDATION
  • EXTERNAL GRANT OR CONTRACT
    KAINIC ACID MODEL
    EPILEPSY FNDN7 Jan 2003 - 31 Dec 2004
    EPILEPSY FNDN